HYTRIN-7 TABS 1MG-7 TABS 2MG-14 TABS 5MG · 1 MG + 5 MG + 2 MG · TABLET / KIT
Médicament · Health Canada · Canada
-
DIN
02187876 -
Code de médicament DPD
20161 -
ATC
G04CA03 -
AIG
0336814001
Ce que publie la source
- Titulaire
- ABBOTT LABORATORIES, LIMITED
- Forme
- TABLET / KIT
- Voies d’administration
- ORAL
- Statut administratif
- cancelled
- Régime de délivrance
- PRESCRIPTION
- Prescription
- Sur ordonnance ou à délivrance restreinte
Noms permettant de trouver cette fiche
- HYTRIN-7 TABS 1MG-7 TABS 2MG-14 TABS 5MG · 1 MG + 5 MG + 2 MG · TABLET / KIT
- HYTRIN-7 TABS 1MG-7 TABS 2MG-14 TABS 5MG
- TERAZOSIN (TERAZOSIN HYDROCHLORIDE)
- Térazosine (Chlorhydrate de térazosine)
Données complètes de la source
{
"din": "02187876",
"form": "TABLET / KIT",
"name": "HYTRIN-7 TABS 1MG-7 TABS 2MG-14 TABS 5MG · 1 MG + 5 MG + 2 MG · TABLET / KIT",
"holder": "ABBOTT LABORATORIES, LIMITED",
"routes": [
"ORAL"
],
"smpcUrl": null,
"atcCodes": [
"G04CA03"
],
"drugCode": "20161",
"marketed": false,
"packages": [
{
"upc": "",
"size": "",
"type": "",
"typeFr": "",
"drugCode": "20161",
"sizeUnit": "",
"sizeUnitFr": "",
"information": "1 EA"
}
],
"brandName": "HYTRIN-7 TABS 1MG-7 TABS 2MG-14 TABS 5MG",
"updatedAt": "22-MAR-2025",
"useDomain": "human",
"descriptor": null,
"leafletUrl": null,
"statusDate": "17-OCT-2006",
"biosimilars": [],
"brandNameFr": null,
"descriptorFr": null,
"productClass": "Human",
"publishedDin": "02187876",
"sourceStatus": "CANCELLED POST MARKET",
"supplyRegime": "PRESCRIPTION",
"targetSpecies": [],
"categorization": null,
"ingredientGroup": "0336814001",
"publicationDate": "2026-11-02",
"sourcePartition": "cancelled",
"dinNotApplicable": false,
"activeIngredients": [
{
"base": "N",
"code": "11368",
"name": "TERAZOSIN (TERAZOSIN HYDROCHLORIDE)",
"unit": "MG",
"nameFr": "Térazosine (Chlorhydrate de térazosine)",
"strength": "1",
"dosageUnit": null,
"dosageValue": null,
"strengthType": null,
"suppliedIndicator": "I"
},
{
"base": "N",
"code": "11368",
"name": "TERAZOSIN (TERAZOSIN HYDROCHLORIDE)",
"unit": "MG",
"nameFr": "Térazosine (Chlorhydrate de térazosine)",
"strength": "5",
"dosageUnit": null,
"dosageValue": null,
"strengthType": null,
"suppliedIndicator": "I"
},
{
"base": "N",
"code": "11368",
"name": "TERAZOSIN (TERAZOSIN HYDROCHLORIDE)",
"unit": "MG",
"nameFr": "Térazosine (Chlorhydrate de térazosine)",
"strength": "2",
"dosageUnit": null,
"dosageValue": null,
"strengthType": null,
"suppliedIndicator": "I"
}
],
"useDomainEvidence": {
"basis": "publisher-field",
"field": "class",
"value": "Human",
"version": 1,
"sourceId": "ca.health-canada.dpd"
},
"identifierWarnings": [],
"patientEligibility": "not-assessed",
"numberOfIngredients": "3",
"targetSpeciesStatus": "not-applicable",
"administrativeStatus": "cancelled",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"pharmaceuticalStandards": [
"MFR"
]
}
Lisez cette fiche depuis votre propre logiciel
La même fiche, avec tous ses champs et sa provenance, est à portée d’une requête. Une clé API est gratuite et fonctionne immédiatement.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=ca" \
--data-urlencode "sourceId=ca.health-canada.dpd" \
--data-urlencode "id=ca:health-canada:products:20161"